Gijs Hardenberg

1.9k total citations
18 papers, 1.2k citations indexed

About

Gijs Hardenberg is a scholar working on Immunology, Molecular Biology and Genetics. According to data from OpenAlex, Gijs Hardenberg has authored 18 papers receiving a total of 1.2k indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Immunology, 6 papers in Molecular Biology and 6 papers in Genetics. Recurrent topics in Gijs Hardenberg's work include Immune Cell Function and Interaction (10 papers), Immune Response and Inflammation (9 papers) and T-cell and B-cell Immunology (8 papers). Gijs Hardenberg is often cited by papers focused on Immune Cell Function and Interaction (10 papers), Immune Response and Inflammation (9 papers) and T-cell and B-cell Immunology (8 papers). Gijs Hardenberg collaborates with scholars based in Netherlands, France and Canada. Gijs Hardenberg's co-authors include Jan Paul Medema, Michael Hahne, Lourdes Planelles, Megan K. Levings, Douglas R. Green, Marianne J.B. van Stipdonk, Edward E. Lemmens, Stephen P. Schoenberger, Martijn S. Bijker and Nathalie Droin and has published in prestigious journals such as Journal of Clinical Investigation, Nature Communications and Nature Immunology.

In The Last Decade

Gijs Hardenberg

18 papers receiving 1.2k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Gijs Hardenberg Netherlands 13 841 263 179 144 120 18 1.2k
Zhiliang Wang China 17 894 1.1× 317 1.2× 167 0.9× 90 0.6× 103 0.9× 26 1.3k
Bellinda A. Bladergroen Netherlands 17 471 0.6× 399 1.5× 200 1.1× 68 0.5× 156 1.3× 19 1.0k
Stephen E. Maher United States 22 844 1.0× 532 2.0× 338 1.9× 164 1.1× 128 1.1× 35 1.4k
Barbara J. Vilen United States 18 860 1.0× 271 1.0× 115 0.6× 95 0.7× 54 0.5× 31 1.2k
Cathy Quilici Australia 16 698 0.8× 259 1.0× 239 1.3× 90 0.6× 62 0.5× 18 1.1k
Stephen B. Gauld United States 21 1.2k 1.5× 361 1.4× 296 1.7× 174 1.2× 69 0.6× 40 1.8k
Andreas Kerstan Germany 20 550 0.7× 406 1.5× 167 0.9× 47 0.3× 98 0.8× 59 1.3k
Randy Fischer United States 15 885 1.1× 284 1.1× 151 0.8× 66 0.5× 155 1.3× 26 1.3k
Marion Espéli France 21 1.0k 1.2× 484 1.8× 395 2.2× 72 0.5× 99 0.8× 50 1.6k
L. D. Shultz United States 9 654 0.8× 568 2.2× 222 1.2× 110 0.8× 63 0.5× 13 1.1k

Countries citing papers authored by Gijs Hardenberg

Since Specialization
Citations

This map shows the geographic impact of Gijs Hardenberg's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Gijs Hardenberg with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Gijs Hardenberg more than expected).

Fields of papers citing papers by Gijs Hardenberg

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Gijs Hardenberg. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Gijs Hardenberg. The network helps show where Gijs Hardenberg may publish in the future.

Co-authorship network of co-authors of Gijs Hardenberg

This figure shows the co-authorship network connecting the top 25 collaborators of Gijs Hardenberg. A scholar is included among the top collaborators of Gijs Hardenberg based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Gijs Hardenberg. Gijs Hardenberg is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

18 of 18 papers shown
1.
Koornneef, Annemart, Kanika Vanshylla, Gijs Hardenberg, et al.. (2024). CoPoP liposomes displaying stabilized clade C HIV-1 Env elicit tier 2 multiclade neutralization in rabbits. Nature Communications. 15(1). 3128–3128. 4 indexed citations
2.
Hardenberg, Gijs, et al.. (2024). Polymeric nanoparticle-based mRNA vaccine is protective against influenza virus infection in ferrets. Molecular Therapy — Nucleic Acids. 35(1). 102159–102159. 5 indexed citations
3.
Montané, Joel, Mercè Obach, Derek L. Dai, et al.. (2015). CCL22 Prevents Rejection of Mouse Islet Allografts and Induces Donor-Specific Tolerance. Cell Transplantation. 24(10). 2143–2154. 24 indexed citations
4.
Hardenberg, Gijs, Yu Yao, Ciriaco A. Piccirillo, Megan K. Levings, & Theodore S. Steiner. (2011). Toll-like receptor 5 deficiency protects from wasting disease in a T cell transfer colitis model in T cell receptor-β-deficient mice. Inflammatory Bowel Diseases. 18(1). 85–93. 11 indexed citations
5.
Hardenberg, Gijs, Theodore S. Steiner, & Megan K. Levings. (2011). Environmental influences on T regulatory cells in inflammatory bowel disease. Seminars in Immunology. 23(2). 130–138. 34 indexed citations
6.
Montané, Joel, Galina Soukhatcheva, Derek L. Dai, et al.. (2011). Prevention of murine autoimmune diabetes by CCL22-mediated Treg recruitment to the pancreatic islets. Journal of Clinical Investigation. 121(8). 3024–3028. 85 indexed citations
7.
Ivison, Sabine, Megan E. Himmel, Gijs Hardenberg, et al.. (2009). TLR5 is not required for flagellin-mediated exacerbation of DSS colitis. Inflammatory Bowel Diseases. 16(3). 401–409. 25 indexed citations
8.
Kimberley, Fiona C., Katherine Cameron, Gijs Hardenberg, et al.. (2009). The proteoglycan (heparan sulfate proteoglycan) binding domain of APRIL serves as a platform for ligand multimerization andcross‐linking. The FASEB Journal. 23(5). 1584–1595. 68 indexed citations
9.
Himmel, Megan E., Gijs Hardenberg, Ciriaco A. Piccirillo, Theodore S. Steiner, & Megan K. Levings. (2008). The role of T‐regulatory cells and Toll‐like receptors in the pathogenesis of human inflammatory bowel disease. Immunology. 125(2). 145–153. 125 indexed citations
10.
Hardenberg, Gijs, et al.. (2008). APRIL affects antibody responses and early leukocyte infiltration, but not influenza A viral control. Molecular Immunology. 45(11). 3050–3058. 6 indexed citations
11.
Planelles, Lourdes, Jan Paul Medema, Michael Hahne, & Gijs Hardenberg. (2008). The Expanding Role of APRIL in Cancer and Immunity. Current Molecular Medicine. 8(8). 829–844. 33 indexed citations
12.
Hardenberg, Gijs, Leticia Fernández, Jenny Hendriks, et al.. (2008). APRIL facilitates viral-induced erythroleukemia but is dispensable for T cell immunity and lymphomagenesis. Journal of Leukocyte Biology. 84(2). 380–388. 6 indexed citations
13.
Hardenberg, Gijs, et al.. (2008). Thymus‐independent class switch recombination is affected by APRIL. Immunology and Cell Biology. 86(6). 530–534. 30 indexed citations
14.
Hardenberg, Gijs, et al.. (2007). Specific TLR ligands regulate APRIL secretion by dendritic cells in a PKR‐dependent manner. European Journal of Immunology. 37(10). 2900–2911. 52 indexed citations
15.
Hendriks, Jenny, Lourdes Planelles, Gijs Hardenberg, et al.. (2005). Heparan sulfate proteoglycan binding promotes APRIL-induced tumor cell proliferation. Cell Death and Differentiation. 12(6). 637–648. 183 indexed citations
16.
Planelles, Lourdes, Carla Eponina Carvalho-Pinto, Gijs Hardenberg, et al.. (2004). APRIL promotes B-1 cell-associated neoplasm. Cancer Cell. 6(4). 399–408. 117 indexed citations
17.
Stipdonk, Marianne J.B. van, Gijs Hardenberg, Martijn S. Bijker, et al.. (2003). Dynamic programming of CD8+ T lymphocyte responses. Nature Immunology. 4(4). 361–365. 333 indexed citations
18.
Medema, Jan Paul, Lourdes Planelles, Gijs Hardenberg, & Michael Hahne. (2003). The uncertain glory of APRIL. Cell Death and Differentiation. 10(10). 1121–1125. 44 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Zhiliang Wang Breakdown of academic impact, for papers by Bellinda A. Bladergroen Breakdown of academic impact, for papers by Stephen E. Maher Breakdown of academic impact, for papers by Barbara J. Vilen Breakdown of academic impact, for papers by Cathy Quilici Breakdown of academic impact, for papers by Stephen B. Gauld Breakdown of academic impact, for papers by Andreas Kerstan Breakdown of academic impact, for papers by Randy Fischer Breakdown of academic impact, for papers by Marion Espéli Breakdown of academic impact, for papers by L. D. Shultz
Rankless by CCL
2026